Applied Food Sciences Receives GRAS "No Comment" Letter for AMATEA® Organic Guayusa Extract
AMATEA® is a branded guayusa extract that uses a patented extraction process to highlight the caffeine and antioxidants
Applied Food Sciences (AFS) takes another step in furthering the safety and validation of its AMATEA® organic guayusa extract by presenting its GRAS dossier to the Food and Drug Administration for review. AMATEA® is a branded guayusa extract that uses a patented extraction process to highlight the caffeine and antioxidants naturally occurring in guayusa leaves to provide premium, organic energy. The industry generally regards the FDA's merited 'no further comment' response as the best response from the FDA and an acknowledgment of the reliable safety data in support of the ingredient. The FDA's 'No Comment' indicates that the FDA has reviewed AFS's safety data and does not disagree with their conclusion that AMATEA® is safe for the intended use in food and beverage applications set out in the dossier.
To assist in completing their dossier, AFS turned to one of the oldest and most trusted natural products compliance firms in North America. "AIBMR Life Sciences was proud to partner with Applied Food Sciences to use our GRAS expertise to help them achieve this historical first 'no questions letter' from the FDA's Office of Food Additive Safety (OFAS) for a natural caffeine-containing botanical ingredient," says John Endres, chief scientific officer, AIBMR Life Sciences.